⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 1, 2024Anais Brasileiros de DermatologiaOpen Access

Factors associated with non-pathogenic antibodies against desmoglein-3 in pemphigus foliaceus

Sebastián Vernal Tamíris Amanda Júlio Fernando Henrique Alves Aline Turatti Eduardo Antônio Donadi Ana Maria Ferreira Roselino

View Full Paper

Ask AI

Bookmark

Share

Abstract

Anti-desmoglein (Dsg)1 is produced in pemphigus foliaceus (PF), affecting exclusively the skin. Pemphigus vulgaris (PV) shows the production of anti-Dsg3 in the mucosal form, and anti-Dsg1 and 3 in the mucocutaneous form. Anti-Dsg3 autoantibodies have been rarely reported in PF.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Vernal et al. (2024) studied this question.

synapsesocial.com/papers/68e67069b6db6435875fb1f4 https://doi.org/10.1016/j.abd.2023.11.006

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Role of desmoglein-3 domains in the pathogenesis of pemphigus2025
2Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleinsOriginal Research · 1997 · 484 citations
3IgG reactivity to different desmoglein-3 ectodomains in pemphigus vulgaris: novel panels for assessing disease severity2024 · 2 citations
4Correlation of Clinical and Histopathological Features With Anti‐Desmoglein Antibody Profile in Pemphigus PatientsRetrospective Study · 2026 · 1 citations
5Pathogenic Role of Avidity of Autoantibodies to Desmogleins 3 and 1 in Pemphigus VulgarisOriginal Research · 2026